Transient erythroblastopenia of childhood (TEC), congenital hypoplastic anemia (CHA), and iron deficiency anemia (IDA) are characterized by anemia, reticulocytopenia, and decreased erythropoiesis. Differences in erythrocyte size, enzyme activities, membrane antigens, hemoglobin F, and protoporphyrin content; serum iron, iron-binding capacity, and ferritin levels; and spontaneous recovery from TEC are significantly diagnostic to differentiate these conditions. Inhibitors of heme production have not been found in CHA serum. To determine if inhibitors of heme production occur in TEC or IDA 1 ml human bone marrow cultures were incubated under controled conditions in pairs with and without erythropoietin (EPO) added. Fe5' was added to the cultures for the last 4 hours of incubation and EPO stimulated Fe5' heme production measured. To check for inhibitor activity, 1 ~1 of test serum was added to culture pairs. Serum from 8 untransfused TEC patients produced a 23+22% inhibition of ~e~~ heme production. In contrast, serum from 2 untransfused CHA and 7 IDA children produced a 43+34% stimulation of FeSs heme production. As recovery occurred, serial serum specimens from 2 TEC patients demonstrated gradual disappearance of inhibitor activity. We conclude that a transient inhibitor of heme production occurs in TEC but not in CHA or IDA. This inhibitor may an immune response and be the mechanism for anenia in TEC.
1 ~1 of test serum was added to culture pairs. Serum from 8 untransfused TEC patients produced a 23+22% inhibition of ~e~~ heme production. In contrast, serum from 2 untransfused CHA and 7 IDA children produced a 43+34% stimulation of FeSs heme production. As recovery occurred, serial serum specimens from 2 TEC patients demonstrated gradual disappearance of inhibitor activity. We conclude that a transient inhibitor of heme production occurs in TEC but not in CHA or IDA. This inhibitor may an immune response and be the mechanism for anenia in TEC.
-, le of bacterial and viral infections as a cause of fever in ildren with acute leukemia (AL) and to determine iE respiratory nd gastrointestinal colonization could predict subsequent bacerial infection. 47 children with newly diagnosed AL had viral nd bacterial cultures and serum obtained at the time of diagosis, during febrile episodes and at the time of periodic clinic isits while asymptomatic and afebrile. 72 febrile episodes were ocumented. (27 during the initial induction phase and 45 subequently.) A cause for the fever was found on 31 occasions and mong those 15 bacterial and 9 viral agents were isolated. In 7 thers with pneumonia or otitis media no etiologic agent was ound. Of the 31 episodes of documented infections, 20 occurred uring induction or relapse, and 11 while in remission.
Colonization of the upper respiratory or gastrointestinal ract with the infectious agents was documented prior to the inection in only 4 of the 15 bacterial infections.
It is concluded that (1) viruses as well as bacteria are sigificant infectious agents in children with AL and (2) the bacerial infections were predictable in 4 of the 15 cases by peridic determinations of the flora during afebrile periods. In his series no deaths occurred as the result of viral infection GROWTH AND DEVELOPMENT IN CHILDREN WITH SICKLE CELL TRAIT: A MATCHED-PAIR PROSPECTIVE STUDY. Michael S. Kramer, Yolanda Rooks, and Howard A. Pearson, Yale U. kch. of Med., Yale-New Haven Hosp., Dept. of Ped., New Haven,Ct
To remove the methodologic flaws of studies claiming that sickle cell trait (Hb AS) impairs physical growth and cognitive ievelopment, we prospectively investigated 25 matched pairs (50 subjects) of Black children chosen from a cord blood electrophoresis screening program. For each child with Hb AS, an Hb AA child was matched at birth for sex, birth date, birth weight, gestational age, 5' Apgar score, and socioeconomic status. At ages 3-5 years, each child was evaluated, within one month of his match, by persons "blind" to the hemoglobin genotype. The results are shown below, together with Pa (probability of no difference) and Pg (probability of missing a true AA-AS difference as larae 'as A): Erythrogenesis imperfecta usually begins in infancy and responds to steroid therapy. Because recent observations indicate a widening spectrum, attention to significant variants is important. The K family presents several unusual findings of erythroid hypoplasia syndrome. Well documented episodes of severe anemia due to marrow erythroid hypoplasia (ErHy) has occured in three generations in 3 females and 4 males and is transmitted as an autosomal dominant. In each the anemia presents in the neonatal period. The affected females have had recurrence of severe anemia in each of 6 pregnancies which have spontaneously remitted at parturition. Transfusions are required to maintain hemoglobin above 5 Gm%. The anemia has been normocytic normochromic with M.C.V. in normal range. The innumerable bone marrow examinations have been typical ErHy while in exacerbation but normal during remission. An important difference from other reports is chat during the 20 years this family has been followed, therapy with steroids has not been sucessfull. A most remarkable observation has been a reticulocyte response to diathermy treatment noted on several occasions. The female infants remit by 2 years of age whereas the males do not fully respond until 5 years of age. No evidence of thymoma has been seen in this family. All affected individuals have normal growth and development. The pathogenesis of this distinctly different ErHy is currently under investigation. This family provides an important addition to our knowledge of uure red cell anemia.
, SUNY at Stony roup A was born to normal mothers (NM) and suckled on iron deicient anemic mothers (AM) until 21 days of age. This group wal subdivided into Group A1 fed an iron deficient diet until 49 day! f age and then given IM iron plus an iron sufficient diet (ISD) nd Group A2 given IM iron plus ISD from 21 days. Group B was rn to AM and suckled on NM and thereafter fed an ISD and Group ups of AM (Group B) had significantly lower body weight, hemolobin (Hb), brain DNA; spleen weight, DNA, protein and iron ompared to pups of NM (Group C). At 21 days, Group A2 had sigificantly lower body weight, Hb, serum iron, brain weight and ron; liber weight, DNA, RNA, protein and iron; spleen weight, Group C. There was no significant difference between Group B serum iron1 brain weight, DNA and iron; liver weight, DNA, , protein and iron; spleen RNA and iron; kidney weight, DNA, A, protein and iron compared to Group C. At 102 days, no sigificant differences were observed in any parameters in all roups. Iron deficiency in rats in utero and during weaning eriods results in significant cellular changes in brain, liver, pleen and kidney which are corrected by iron administration. To determine if children with acute lymhoblastic leukemia (ALL) can mount a primary response to immunization with a new antigen and a secondary response to a known antigen, 39 children with A U and 51 sibling controls received 2 doses of bivalent split-product influenza vaccine, A Victoria/75, A New Jersey/76 (A/Vic, A/NJ). Before immunization 90% of patients and controls had hemagglutination inhibitinq antibody (HAI) to A/Vic ofrl:R; none showed HA1 antibodies to A/NJ. Four weeks after the first dose 74% of patients and controls showed at least a 4-fold rise in HA1 titer to WVic. Only 48% of patients on chemotherapy responded to the first A/NJ immunization compared to 68% of controls and 89% of patients off therapy. Following the second dose, 86% of patients on therapy demonstrated at least a 4-fold rise in titers to both viruses with geometric mean titers of 1:68 to A/Vic and 1:43 to A/NJ. Patients who were off therany developed higher HA1 titers than controls. The results demonstrate that patients receiving chemotherapy can orduce anti-influenza antibody in response to immunization with either an old antiqen or a new antigen. Responses to the new antigen in patients on chemotherapy are imre sluggish than those of controls but adequate antibody levels are achieved with booster immunization.
